[3H] Pyridoxamine was orally administered to mice in physiological amounts, and the distribution of isotope between the six recognized forms of vitamin B6 and pyridoxac acid was determined at different times in the intestine, liver, blood, and brain. After 7min about 50% of the radioactivity in pyridoxamine had been absorbed by the intestine and transported to the blood and other organs. Labeled pyridox al phosphate was found in the intestine and liver. Labeled pyridoxamine could not be detected in the peripheral blood, but substantial amounts of labeled pyridoxal and pyridoxal phosphate were found in the blood. However, when a large amount (40-140nmol) was given, a significant amount of labeled pyridoxamine was found in the blood, together with labeled pyridoxal and pyridoxal phosphate. These results suggest that the intestine and/or liver play a major role in completely converting physio logical amounts of pyridoxamine to circulating pyridoxal, which is then taken up and phosphorylated by other organs.
The general pathway for the metabolic interconversion of B6 vitamers is well known. For example, pyridoxine (PN) and pyridoxamine (PM) are phosphory lated to pyridoxine phosphate (PNP) and pyridoxamine phosphate (PMP), re spectively, by pyridoxal (PL) kinase, which has been detected in all mammalian tissues investigated (1) . PNP and PMP are commonly converted to pyridoxal phosphate (PLP) by pyridoxine phosphate (PNP) oxidase (2) , which, in contrast to the wide distribution of PL kinase, is confined to a few tissues (3) (4) (5) (6) (7) (8) . The great activity of PNP oxidase is found in the liver, with only limited activity in the intestine, brain, and kidney, and almost no activity in the lung, heart, muscles, and pancreas. PLP can be converted to PL by hydrolysis with phosphatase (9). Part of T. SAKURAI et al.
the PL is then converted again to PLP by PL kinase and the remaining part is oxidized to pyridoxic acid by PL oxidase (4) .
Our previous work (10, 11) has shown that, when a physiological dose of pyridoxine (PN) is orally administered to mice, PN is completely converted to circulating PL by sequential participation of PL kinase, PNP oxidase and phos phatase of the intestine and/or liver, and thus PL may be used as the only source of PLP for most tissues. This result suggests that when PM is given as a dietary B6 vitamer it may be completely converted to circulating PL by the same enzyme system described above.
In this study, various amounts of [3H] PM were orally administered to mice , and the distribution of isotope among B6 vitamers in various organs, including blood, was determined to investigate the absorption and metabolism of the vitamers in live animals.
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DISCUSSION
The present experiment shows that, although [3H] PM in physiological amounts is rapidly absorbed across the intestinal wall, it is not found in the circulating blood. Instead of [3H] PM, a noticeable amount of [3H] PL appeared rapidly in the blood (Fig. 1c) . These results suggest that PM is taken up by the intestinal wall and liver and converted there to PL, with only the product PL released into the circulating blood. (6, 8, (15) (16) (17) . The intestine and liver may provide a means of completely converting dietary PM to circulatory PL, which can then serve as the only source of the coenzyme PLP in all tissues that contain PL kinase, whether they contain PNP oxidase or not . The results shown in the present report suggest that in a physiological state PL may play a very important role in transport between organs and may be the only source of PLP for these cells.
[3H] PLP in the brain (Fig. 1d) therefore is considered to have come from [3H] PL in the blood.
The observation that most [3H] PL in the blood is located in the plasma (Fig .  2a) suggests that plasma PL may be the source of PLP for most tissues and that the loose binding of PL to plasma albumin (18) and the resulting accumulation of this vitamer in the plasma may provide a means for PL to function as a principal form of transport in the blood (Fig. 4) .
In any case, it is important to note that when a physiological level of PM is orally administered to mice, no PM reaches the circulating blood; rather, PL appears as the only form in the circulating blood. In this condition, therefore, all organs other than the intestine and liver are thought to obtain not PM but PL from the plasma and then convert it to PLP via PL kinase. Whether the [3H] PL found in the blood originated in the intestine wall or liver or both remains to be clarified in future experiments.
When amounts of [3H] PM larger than 46nmol were administered , a consid erable amount of [3H] PM appeared in the blood without being completely trans formed to [3H] PL (Fig. 3) . This result suggests that the ability of the intestinal wall and/or liver to completely convert dietary PM to circulating PL has a limit and that this limit is between 14 and 46nmol of PM per mouse. The PM that leaked into the circulation was distributed to the plasma. This leaked PM in plasma may serve as a source of the coenzyme PLP in some tissues that contain both PL kinase and PNP oxidase.
Our previous reports have already shown that when less than 46nmol of PN is given orally to mice, PN is entirely transformed to PL, which can serve as the only source of vitamin B6 for most tissues (10, 11) . Thus, it is important to note that when a physiological level of B6 vitamers (PN and PM) is administered orally to mice each vitamer is entirely transformed to PL in the intestinal wall and/or liver, and only this PL is used as a principal source of vitamin B6 by tissues and organs.
